-
New Approach Announced for Processing Complaints to the FDA
The U.S. Food and Drug Administration (FDA) announced a major improvement in its system for processing complaints today.…
-
FDA Announces Recalls for Plastic Syringes Made in China
The FDA has announced added recalls initiated by Medline Industries, LP concerning plastic syringes manufactured in China. The…
-
FDA Approved Semaglutide Injection to Reduce Risk of Serious Heart Problems in Overweight Adults
On March 8, 2024, The U.S. FDA has approved Wegovy (semaglutide) injection, a weight management medication also designed…
-
First Over-the-Counter Glucose Monitor Gets Clearance From the FDA
The U.S. Food and Drug Administration (FDA) has granted marketing clearance to the first over-the-counter continuous glucose monitor…
-
CDC Released Updated Recommendations for Respiratory Virus
On March 1, 2024, the Center for Disease Control and Prevention (CDC) released updated guidelines for combatting respiratory…
-
First Transcatheter Therapy for Tricuspid Valve Replacement Gains FDA Approval
On February 1, Edwards EVOQUE Tricuspid Valve Replacement System was approved by the FDA. The system treats patients…
-
Janus Kinase Inhibitor Treatment Approved for Severe Alopecia Areata
Alopecia is a devastating tissue-specific autoimmune condition caused by the T-cell-mediated destruction of hair follicles. This leads to…
-
New Therapy for Sickle Cell Disease
Sickle cell disease (SCD) is an inherited genetic mutation causing normally round or disc-shaped cells to develop as…
-
FDA Deems Phenylephrine ‘Ineffective’
Phenylephrine, the mainstay in many OTC nasal decongestant preparations such as Dayquil and Sudafed, and some nasal sprays,…
-
FDA Reevaluates Over-the-Counter Cold Medications
Phenylephrine, a key ingredient in many over-the-counter cold preparations, has been re-evaluated by the FDA Advisory panel who…
-
Hyperlipidemia treatments gaining popularity
Two newer FDA-approved treatments for hyperlipidemia are gaining popularity due to their effectiveness and dosing. A statin alternative,…
-
New Oral Medication to Treat Postpartum Depression Approved by FDA
Between 6.5% and 20% of new mothers develop postpartum depression (PPD), though many more may go undiagnosed. PPD…
Trending
-
FDA Approved Semaglutide Injection to Reduce Risk of Serious Heart Problems in Overweight Adults
-
The Role of Pharmacogenomics in Precision Mental Healthcare
-
OTC COVID-19 Diagnostic Tests May Have an Extended Shelf Life
-
AANP Offers Resources to Help NPs Detect and Treat Ulcerative Colitis
-
Multistate Outbreak of Salmonella Linked to Cucumbers
-
5 Key Benefits of Getting a Second Certification as a Nurse Practitioner
-
8 Key Tips for Effective Communication During Pediatric ENT Exams
-
Normalizing Anxiety: How NPs Can Guide Patients to Make Healthier Choices
-
CDC Endorses Lowering Pneumococcal Vaccination Age from 65 to 50
-
FDA Proposes Ban on Over-the-Counter Oral Nasal Congestion Medication
-
Using Technology to Combat Drug-Drug Interactions
-
Building a Strong Professional Nursing Network as a New Nurse Practitioner
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.